Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

September 16, 2014
Bioniche Files Final Prospectus For Equity Offering

August 22, 2014
Bioniche Life Sciences Announces Terms of $5 Million Financing & Use of Proceeds

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Financial

September 2014

16/09/14
Bioniche Files Final Prospectus For Equity Offering

August 2014

22/08/14
Bioniche Life Sciences Announces Terms of $5 Million Financing & Use of Proceeds

May 2014

14/05/14
Bioniche Life Sciences Inc. Reports Fiscal 2014 Third Quarter Results

February 2014

06/02/14
Bioniche Life Sciences Inc. Reports Fiscal 2014 Second Quarter Results and Announces Strategic Expenditure Review and New One Health Strategy

December 2013

11/12/13
Bioniche Life Sciences Inc. Delisting Approved by the ASX

November 2013

07/11/13
Bioniche Life Sciences Inc. Reports Fiscal 2014 First Quarter Results

October 2013

18/10/13
Bioniche Management Proxy Circular for 2013 Annual and Special Meeting Now Available

September 2013

27/09/13
Bioniche Life Sciences Inc. Reports Fiscal 2013 Year-End Results

26/09/13
Bioniche Closes Canadian Equity Offering and Related Private Placement

18/09/13
Bioniche Files Final Prospectus for Canadian Equity Offering

12/09/13
Bioniche Life Sciences Inc. and Concerned Shareholders Announce a Settlement

August 2013

07/08/13
Bioniche Confirms Pricing of Canadian Equity Offering

06/08/13
Bioniche Files Preliminary Prospectus for Canadian Equity Offering

June 2013

28/06/13
Bioniche Responds to Dissident Shareholders' Latest Tactics

05/06/13
Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin™ Licensing Deals

May 2013

08/05/13
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

04/05/13
Bioniche Life Sciences Inc. Responds to Dissident Request for Shareholder Meeting

April 2013

26/04/13
Bioniche Life Sciences Inc. Acknowledges Request for Shareholder Meeting

19/04/13
Bioniche Life Sciences Inc. Experiences Increased Trading Activity

March 2013

26/03/13
Bioniche Life Sciences Inc. Reacts to Canadian Federal Budget

February 2013

06/02/13
Bioniche Life Sciences Inc. Reports Q2, Fiscal 2013 Results

November 2012

07/11/12
Bioniche Life Sciences Inc. Reports Q1, Fiscal 2013 Results

September 2012

12/09/12
Bioniche Life Sciences Inc. Reports Fiscal 2012 Year-End Results

May 2012

09/05/12
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2012 Results

April 2012

11/04/12
Bioniche Life Sciences Inc. Closes US$20M Financing from Capital Royalty L.P.

March 2012

19/03/12
Bioniche Life Sciences Inc. Accepts US$20M Financing Offer from Capital Royalty L.P.

February 2012

09/02/12
Bioniche Life Sciences Inc. Reports Q2, Fiscal 2012 Results

09/02/12
Bioniche Life Sciences Inc. Q2, Fiscal 2012 Conference Call and Audio Webcast

December 2011

12/12/11
Bioniche Life Sciences Inc. Reports Q1, Fiscal 2012 Results

September 2011

22/09/11
Bioniche Life Sciences Inc. Outlines Plan to Achieve Profitability

15/09/11
Bioniche Reports Fiscal 2011 Year-End Results

May 2011

11/05/11
Bioniche Life Sciences Inc. Reports Fiscal 2011 Third Quarter Results

February 2011

10/02/11
Bioniche Life Sciences Inc. Reports Fiscal 2011 Second Quarter Results

January 2011

27/01/11
Bioniche Life Sciences Inc. Securities Now Trading on the Australian Securities Exchange (ASX)

20/01/11
Bioniche Life Sciences Inc. Listing on the Australian Securities Exchange (ASX)

04/01/11
Bioniche Completes Australian Offer, Raising A$12.5 Million

December 2010

16/12/10
Bioniche Closes Canadian Portion of 20 Million Common Share Offer

14/12/10
Canadian Underwriters Exercise Over-Allotment Option as Part of Bioniche Share Offer

13/12/10
Bioniche Files Final Documentation for Canadian Portion of 20 Million Common Share Offer

10/12/10
Bioniche Prices Canadian Portion of 20 Million Common Share Offer

November 2010

22/11/10
Bioniche Files Regulatory Documents for 20 Million Common Share Offer in Canada and Australia

10/11/10
Bioniche Reports Fiscal 2011 First Quarter Results

October 2010

19/10/10
Fonds de solidarité FTQ Converting
Remainder of its Preferred Shares in Bioniche

September 2010

27/09/10
Bioniche Experiences Increased Trading Activity

10/09/10
Bioniche Reports Fiscal 2010 Year-End Results

May 2010

12/05/10
Bioniche Reports Fiscal 2010 Third Quarter Results

February 2010

10/02/10
Bioniche Reports Fiscal 2010 Second Quarter Results

November 2009

06/11/09
Bioniche Reports Fiscal 2010 First Quarter Results And Achievement of First Milestone Under Licensing Agreement

September 2009

21/09/09
Bioniche Reports Fiscal 2009 Year-End Results

July 2009

20/07/09
Bioniche Repays Revolving Credit Facility

May 2009

06/05/09
Bioniche Reports Fiscal 2009 Third Quarter

March 2009

02/03/09
Bioniche Revolving Credit Facility Maturity Date Amended

February 2009

17/02/09
Bioniche Warrants’ Expiration Date to be Extended

06/02/09
Bioniche Reports Fiscal 2009 Second Quarter

January 2009

14/01/09
Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada

November 2008

07/11/08
Bioniche Reports Fiscal 2009 First Quarter

September 2008

19/09/08
Bioniche Reports Fiscal 2008 Year-End Results

09/09/08
Bioniche Allows Conversion of Portion of Revolving Credit Facility

May 2008

09/05/08
Bioniche Reports Fiscal 2008 Third Quarter

March 2008

27/03/08
Bioniche Converts a Portion of its Debt to Equity

February 2008

12/02/08
Bioniche Reports Fiscal 2008 Second Quarter

December 2007

21/12/07
Bioniche Amends Terms of Convertible Debt with Laurus Master Funds

November 2007

09/11/07
Bioniche Reports Fiscal 2008 First Quarter

September 2007

26/09/07
Bioniche Reports Fiscal 2007 Year-End Results

21/09/07
Bioniche Reports Year-End Fiscal 2007 Results

07/09/07
Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine

July 2007

30/07/07
Bioniche Lists Warrants in Connection with March 7, 2007 Offering of Units

June 2007

06/06/07
Solidarity Fund QFL Converting 25% of its Preferred Shares in Bioniche Life Sciences

May 2007

04/05/07
Bioniche Reports Third Quarter Results for Fiscal 2007

April 2007

18/04/07
Bioniche Eliminates Convertible Debt with Laurus Master Funds

March 2007

13/03/07
Bioniche Closes C$17.5 Million Equity Financing

February 2007

02/02/07
Bioniche Reports Second Quarter Results for Fiscal 2007

December 2006

15/12/06
Bioniche Life Sciences Experiences Significant Trading Volume Following Progress Update on E. coli O157:H7 Cattle Vaccine Canadian Regulatory Status

November 2006

10/11/06
Bioniche Reports First Quarter Results for Fiscal 2007

September 2006

28/09/06
Bioniche Reports Fiscal Year-End Results

22/09/06
Update for Bioniche Year-End Fiscal 2006 Call/Cast Per CNW Group

15/09/06
New Date for Bioniche Year-End Fiscal 2006 Call/Cast

11/09/06
Bioniche Reports Year-End Fiscal 2006 Results

May 2006

09/05/06
Bioniche Third Quarter Results Correction

05/05/06
Bioniche Reports Third Quarter Results for Fiscal 2006

03/05/06
Bioniche Sells Proprietary Cystitis Product for $10 Million Cdn.

02/05/06
Media Advisory - Bioniche Reports Third Quarter Results for Fiscal 2006

February 2006

08/02/06
Bioniche Reports Second Quarter Results for Fiscal 2006

02/02/06
Media Advisory - Bioniche Reports Second Quarter Results for Fiscal 2006

December 2005

09/12/05
Bioniche Completes Private Financing

November 2005

04/11/05
Bioniche Reports First Quarter Results for Fiscal 2006

01/11/05
Bioniche Annual Meeting Web Cast and First Quarter Results for Fiscal 2006

October 2005

14/10/05
Bioniche Discussing Potential Private Placement

September 2005

29/09/05
Bioniche Reports Fiscal Year-End Results and Unveils Plans to Convert Business Unit into Cash

20/09/05
New Date/Time for Bioniche Fiscal 2005 Year-End Call/Cast

15/09/05
Bioniche Reports Year-End Fiscal 2005 Results

May 2005

09/05/05
Bioniche Reports Third Quarter Fiscal 2005 Results

03/05/05
Bioniche Reports Third Quarter Results for Fiscal 2005

February 2005

10/02/05
Bioniche Reports Second Quarter Fiscal 2005 Results

09/02/05
Bioniche Reports Second Quarter Results for Fiscal 2005

November 2004

09/11/04
Bioniche Revenues Increase in First Quarter of Fiscal 2005

October 2004

28/10/04
Investment in Bioniche Life Sciences Inc.The Solidarity Fund QFL will invest $10 M and the Bio-Food Investment Fund $2 Mac

20/10/04
Bioniche Annual Report Correction

September 2004

21/09/04
Bioniche Reports Year-End Fiscal 2004 Results

15/09/04
Bioniche Reports Year-End Fiscal 2004 Results

May 2004

21/05/04
Bioniche’s Pharmaceutical Business Unit Raises 10.8 Million Euro for Expansion of Manufacturing Facilities

14/05/04
Bioniche Reports Third Quarter Fiscal 2004 Results

12/05/04
Bioniche Reports Third Quarter Fiscal 2004 Results Web Cast

February 2004

17/02/04
Bioniche Life Sciences Completes $10,000,000 Financing

13/02/04
Bioniche Reports Second Quarter 2004 Financial Results

05/02/04
Bioniche Enters Into Agreement For $10,000,000 Financing


Newsroom

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy